Sign inJoin waitlistJoin the waitlist

Elma Baron

Clinical Program Director - VISN 10 Teledermatology · Case Western Reserve University

Credentials: · ·

History

Clinical - VISN 10 Teledermatology · Case Western Reserve University
Present
Skin Study Center · Case Western Reserve University
Present
University Hospitals Research Institute · Case Western Reserve University
Present

Dermatology
University of the Philippines College of Medicine

Research

Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies
Review · Toxicology and Applied Pharmacology · 2007 · 139 citations
Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial
Lasers in Surgery and Medicine · 2010 · First of 10 authors · Corresponding · 95 citations
Does poor sleep quality affect skin ageing?
Clinical and Experimental Dermatology · 2015 · Last of 7 authors · 92 citations

Kevin Cooper
34 papers
SS
Seth Stevens
15 papers
AS
Amanda Suggs
8 papers · 8 as a resident
MC
Melissa Camouse
7 papers · 5 as a resident
KH
Kaija Hanneman
6 papers · 5 as a resident
SN
Susan Nedorost
6 papers
Patricia Oyetakin
5 papers · 4 as a resident
EK
Eugene Kirkland
4 papers · 1 as a fellow
JM
Janine Miller
4 papers · 4 as a resident
Charlie Taylor
3 papers
CM
Christi Malbasa
3 papers
Kory Schrom
3 papers · 3 as a fellow

Grants

Phase 1 Study of Pc 4 Photodynamic Therapy for Tx of Cutaneous T-Cell Lymphoma
Food and Drug Administration · R01
Contact PI · $590.7K · Case Western Reserve University
2012–2016
NIAMS: CORT (Psoriasis Center of Research Translation)
National Institute of Arthritis and Musculoskeletal and Skin Diseases · P50
Project lead · $1.7M · Case Western Reserve University
2007–2013
NIAMS Core Center: Skin Diseases Research Center
National Institute of Arthritis and Musculoskeletal and Skin Diseases · P30
Project lead · $204.7K · Case Western Reserve University
2007–2011

Clinical trials

Silicon Phthalocyanine 4 and Photodynamic Therapy in Stage IA-IIA Cutaneous T-Cell Non-Hodgkin Lymphoma
Principal investigator · Completed · Phase 1
Kevin Cooper MD
2013–2015
Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides
Principal investigator · Completed · Phase 1
Case Comprehensive Cancer Center
2004–2010